Alignment Healthcare (NASDAQ:ALHC) President Sells $586,500.00 in Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC) President Dawn Christine Maroney sold 30,000 shares of the firm’s stock in a transaction that occurred on Monday, June 15th. The shares were sold at an average price of $19.55, for a total transaction of $586,500.00. Following the completion of the sale, the president directly owned 947,313 shares of the company’s stock, valued at approximately $18,519,969.15. This represents a 3.07% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Dawn Christine Maroney also recently made the following trade(s):

• On Friday, May 15th, Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock. The shares were sold at an average price of $16.09, for a total transaction of $482,700.00.
• On Wednesday, April 15th, Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock. The stock was sold at an average price of $20.87, for a total transaction of $626,100.00.
• On Wednesday, March 18th, Dawn Christine Maroney sold 36,749 shares of Alignment Healthcare stock. The stock was sold at an average price of $17.84, for a total transaction of $655,602.16.

Alignment Healthcare Trading Up 4.0%

Shares of NASDAQ ALHC opened at $21.42 on Thursday. The company’s fifty day moving average is $18.64 and its 200-day moving average is $19.44. The stock has a market cap of $4.43 billion, a price-to-earnings ratio of 238.00, a P/E/G ratio of 2.78 and a beta of 1.14. Alignment Healthcare, Inc. has a twelve month low of $11.63 and a twelve month high of $23.87. The company has a quick ratio of 1.58, a current ratio of 1.58 and a debt-to-equity ratio of 1.56.

Alignment Healthcare (NASDAQ:ALHC) last announced its quarterly earnings results on Thursday, April 30th. The company reported $0.05 earnings per share for the quarter, topping analysts’ consensus estimates of $0.01 by $0.04. The company had revenue of $1.24 billion for the quarter, compared to analysts’ expectations of $1.22 billion. Alignment Healthcare had a net margin of 0.47% and a return on equity of 11.50%. The business’s quarterly revenue was up 33.3% compared to the same quarter last year. During the same period last year, the firm posted ($0.05) earnings per share. Equities research analysts predict that Alignment Healthcare, Inc. will post 0.2 EPS for the current year.

Wall Street Analyst Weigh In

Several research firms recently commented on ALHC. UBS Group boosted their price objective on shares of Alignment Healthcare from $21.00 to $22.00 and gave the company a “neutral” rating in a research report on Friday, May 1st. Raymond James Financial set a $22.00 price target on shares of Alignment Healthcare in a research report on Thursday, May 7th. Zacks Research raised shares of Alignment Healthcare from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, April 28th. KeyCorp reissued an “overweight” rating on shares of Alignment Healthcare in a research report on Wednesday, June 10th. Finally, Wolfe Research assumed coverage on shares of Alignment Healthcare in a research report on Friday, April 17th. They set an “outperform” rating and a $24.00 price target on the stock. One equities research analyst has rated the stock with a Strong Buy rating, six have given a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $24.30.

Institutional Inflows and Outflows

Institutional investors have recently modified their holdings of the company. Hudson Bay Capital Management LP acquired a new position in shares of Alignment Healthcare during the 3rd quarter worth about $4,581,000. 1492 Capital Management LLC increased its stake in shares of Alignment Healthcare by 61.8% during the 4th quarter. 1492 Capital Management LLC now owns 324,865 shares of the company’s stock worth $6,416,000 after purchasing an additional 124,143 shares during the last quarter. Cinctive Capital Management LP acquired a new position in shares of Alignment Healthcare during the 3rd quarter worth about $3,814,000. Vanguard Group Inc. increased its stake in shares of Alignment Healthcare by 5.0% during the 3rd quarter. Vanguard Group Inc. now owns 13,968,584 shares of the company’s stock worth $243,752,000 after purchasing an additional 664,769 shares during the last quarter. Finally, William Blair Investment Management LLC increased its stake in shares of Alignment Healthcare by 43.4% during the 3rd quarter. William Blair Investment Management LLC now owns 2,119,952 shares of the company’s stock worth $36,993,000 after purchasing an additional 641,381 shares during the last quarter. 86.19% of the stock is currently owned by institutional investors and hedge funds.

About Alignment Healthcare

Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare’s approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.